Poland· PL-100426836
Smecta
A diosmectit product containing diosmectitum, registered in Poland by Pharmapoint SA. The same ATC class is registered in 4 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Diosmectit is registered in 4 of 19 countries.
Countries holding a registration under ATC A07BC05 (diosmectit), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 4 of them publish a price we can compare per daily dose
Diosmectit · ATC A07BC05
4 / 19 countries
- Belgiumprice
- Czechiaprice
- Franceprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Diosmectitum
- Manufacturer
- Pharmapoint SA
- Country
- Poland (PL)
- ATC code
- A07BC05
- ATC class
- Diosmectit
- Defined daily dose
- 9 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991417154
- gtin05909991417161
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A07BC05
Diosmectit, as other registers publish it.
- BelgiumBarexal 3 g - 0.125 gIpsen
- FranceDIOSMECTITE VIATRIS 3 g, poudre pour suspension buvable en sachetOY SIMCERE EUROPE (FINLANDE)
- PolandSmectaAllpharm Sp. z o.o. sp.k.
- PolandSmectaForfarm Sp. z o.o.
- PolandSmectaPharmaVitae Sp. z o.o. sp. k.
- PolandSmectaInPharm Sp. z o.o.
- PolandSmectaMAYOLY PHARMA FRANCE
- PolandSmectaDelfarma Sp. z o.o.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aa6e558e-d9c8-42f9-be55-48f52d5d2620 GET /v1/drugs/aa6e558e-d9c8-42f9-be55-48f52d5d2620?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek do sporządzania zawiesiny doustnej",
"source": "urpl",
"strength": "3 g",
"packaging": "05909991417154 ¦ OTC ¦ 134398\n10 sasz. \n05909991417161 ¦ OTC ¦ 134399\n30 sasz.",
"substance": "Diosmectitum 3 g",
"common_name": "Diosmectitum",
"pl_product_id": "100426836",
"pozwolenie_nr": "390/19",
"auth_procedure": "IR",
"authorisation_validity": "2024-10-18"
}See everything about diosmectit.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.